Based on data generated from prior trials, our vaccine candidates have shown that participants had increased IgA antibodies to SARS-CoV-2, the virus that causes COVID-19, while maintaining ...

I am therefore confident that our approach should be effective not only during future outbreaks of SARS-CoV-2 variants of ...

Cbus Super CEO Kristian Fok is set to appear before the Senate Economics References Committee today in relation to a range of ...

Nufarm (ASX:NUF) has announced its full-year financial results for FY24, reporting a drop in net debt by 25% to $635m.